# Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

> **NCT05265208** · PHASE2 · RECRUITING · sponsor: **Center Eugene Marquis** · enrollment: 62 (estimated)

## Conditions studied

- Resectable Intrahepatic Cholangiocarcinoma

## Interventions

- **DRUG:** Capecitabine
- **DEVICE:** Selective Internal Radiotherapy (SIRT)
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT05265208
- **Lead sponsor:** Center Eugene Marquis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-04
- **Primary completion:** 2027-09-04
- **Final completion:** 2030-02-04
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05265208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05265208, "Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05265208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*